These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15208595)

  • 1. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.
    Bernstein DI; Wanner M; Borish L; Liss GM;
    J Allergy Clin Immunol; 2004 Jun; 113(6):1129-36. PubMed ID: 15208595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of near-fatal reactions to allergen immunotherapy injections.
    Amin HS; Liss GM; Bernstein DI
    J Allergy Clin Immunol; 2006 Jan; 117(1):169-75. PubMed ID: 16387602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists].
    Larenas Linnemann D; Rodríguez Pérez N; Becerril M
    Rev Alerg Mex; 2008; 55(2):62-70. PubMed ID: 19058483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy.
    Lin MS; Tanner E; Lynn J; Friday GA
    Ann Allergy; 1993 Dec; 71(6):557-62. PubMed ID: 8267250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI; Epstein TEG
    Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013).
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):354-359.e2. PubMed ID: 26948485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of allergen immunotherapy: a literature review.
    Cook PR; Farias C
    Ear Nose Throat J; 1998 May; 77(5):378-9, 383-8. PubMed ID: 9615518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of fatalities from skin testing and immunotherapy 1985-1989.
    Reid MJ; Lockey RF; Turkeltaub PC; Platts-Mills TA
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):6-15. PubMed ID: 8335856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorrect allergy injections: allergists' experiences and recommendations for prevention.
    Aaronson DW; Gandhi TK
    J Allergy Clin Immunol; 2004 Jun; 113(6):1117-21. PubMed ID: 15208593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient perceptions regarding local reactions from allergen immunotherapy injections.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):96-100. PubMed ID: 18681091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.
    Moreno C; Cuesta-Herranz J; Fernández-Távora L; Alvarez-Cuesta E;
    Clin Exp Allergy; 2004 Apr; 34(4):527-31. PubMed ID: 15080803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
    Caminati M; Dama AR; Djuric I; Montagni M; Schiappoli M; Ridolo E; Senna G; Canonica GW
    Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic reactions during immunotherapy.
    Rezvani M; Bernstein DI
    Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated late cutaneous reactions to allergen skin testing in children.
    Lierl MB
    Ann Allergy Asthma Immunol; 2000 Mar; 84(3):294-8. PubMed ID: 10752912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods.
    Ragusa VF; Massolo A
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):52-5. PubMed ID: 15061395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
    Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors.
    Epstein TG; Liss GM; Berendts KM; Bernstein DI
    J Allergy Clin Immunol Pract; 2019; 7(6):1996-2003.e1. PubMed ID: 30776526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.